Todd M. Kolb

3.1k total citations
88 papers, 1.8k citations indexed

About

Todd M. Kolb is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Todd M. Kolb has authored 88 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Pulmonary and Respiratory Medicine, 37 papers in Cardiology and Cardiovascular Medicine and 16 papers in Pathology and Forensic Medicine. Recurrent topics in Todd M. Kolb's work include Pulmonary Hypertension Research and Treatments (59 papers), Cardiovascular Function and Risk Factors (18 papers) and Systemic Sclerosis and Related Diseases (14 papers). Todd M. Kolb is often cited by papers focused on Pulmonary Hypertension Research and Treatments (59 papers), Cardiovascular Function and Risk Factors (18 papers) and Systemic Sclerosis and Related Diseases (14 papers). Todd M. Kolb collaborates with scholars based in United States, Italy and Germany. Todd M. Kolb's co-authors include Paul M. Hassoun, Stephen C. Mathai, Rachel L. Damico, Ryan J. Tedford, David A. Kass, Steven Hsu, Rubina Khair, Brian A. Houston, Stefan L. Zimmerman and Peter J. Leary and has published in prestigious journals such as Circulation, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Todd M. Kolb

81 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Todd M. Kolb United States	23	1.3k	993	271	240	202	88	1.8k
Todd M. Bull United States	20	955 0.7×	384 0.4×	309 1.1×	215 0.9×	256 1.3×	34	1.7k
Miguel Ángel Gómez‐Sánchez Spain	22	1.7k 1.3×	1.5k 1.5×	78 0.3×	185 0.8×	364 1.8×	40	2.4k
Satoshi Akagi Japan	21	564 0.4×	488 0.5×	122 0.5×	127 0.5×	209 1.0×	78	1.1k
Laura Scelsi Italy	28	1.4k 1.1×	2.1k 2.1×	127 0.5×	285 1.2×	337 1.7×	105	2.9k
G. Simonneau France	15	1.5k 1.1×	742 0.7×	213 0.8×	112 0.5×	161 0.8×	34	1.7k
Rebecca Vanderpool United States	30	2.6k 1.9×	2.3k 2.3×	78 0.3×	520 2.2×	398 2.0×	81	3.4k
Thomas A. Koeppel Germany	25	767 0.6×	418 0.4×	109 0.4×	309 1.3×	704 3.5×	68	1.8k
Shiro Mizuno Japan	23	1.5k 1.1×	685 0.7×	59 0.2×	181 0.8×	263 1.3×	70	2.1k
Laurence Dewachter Belgium	19	987 0.7×	579 0.6×	40 0.1×	159 0.7×	277 1.4×	62	1.5k
Mikio Kakishita Japan	12	930 0.7×	1.4k 1.4×	51 0.2×	213 0.9×	197 1.0×	32	1.8k

Countries citing papers authored by Todd M. Kolb

Since Specialization

Citations

This map shows the geographic impact of Todd M. Kolb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Todd M. Kolb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Todd M. Kolb more than expected).

Fields of papers citing papers by Todd M. Kolb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Todd M. Kolb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Todd M. Kolb. The network helps show where Todd M. Kolb may publish in the future.

Co-authorship network of co-authors of Todd M. Kolb

This figure shows the co-authorship network connecting the top 25 collaborators of Todd M. Kolb. A scholar is included among the top collaborators of Todd M. Kolb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Todd M. Kolb. Todd M. Kolb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yuli, Sun Ho Ahn, Christopher J. Mullin, et al.. (2025). Abn-BLIP: Abnormality-aligned Bootstrapping Language-Image Pre-training for pulmonary embolism diagnosis and report generation from CTPA. Medical Image Analysis. 107(Pt A). 103786–103786.

Leary, Peter J., Jennifer Yui, Hamza Aziz, et al.. (2025). Effects of Implementing a Standardized Risk Stratification and Triage Workflow for an Established Pulmonary Embolism Response Team. Annals of the American Thoracic Society. 22(10). 1484–1492.

Simpson, Catherine E., Aparna Balasubramanian, Todd M. Kolb, et al.. (2025). Multi-beat pressure–volume loop-derived right ventricular–pulmonary arterial coupling predicts transplant-free survival in pulmonary arterial hypertension. European Respiratory Journal. 67(1). 2500724–2500724.

Yun, Xin, Shannon Niedermeyer, Karthik Suresh, et al.. (2024). Aquaporin 1 confers apoptosis resistance in pulmonary arterial smooth muscle cells from the SU5416 hypoxia rat model. Physiological Reports. 12(16). e16156–e16156. 2 indexed citations

Niedermeyer, Shannon, Xin Yun, Haiyang Jiang, et al.. (2024). A novel interaction between aquaporin 1 and caspase-3 in pulmonary arterial smooth muscle cells. American Journal of Physiology-Lung Cellular and Molecular Physiology. 326(5). L638–L645.

Simpson, Catherine E., Robert Harlan, David R. Graham, et al.. (2023). Spatial and temporal resolution of metabolic dysregulation in the Sugen hypoxia model of pulmonary hypertension. Pulmonary Circulation. 13(3). e12260–e12260. 4 indexed citations

Simpson, Catherine E., Julie Coursen, Steven Hsu, et al.. (2023). Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension. American Journal of Physiology-Lung Cellular and Molecular Physiology. 324(6). L836–L848. 14 indexed citations

Yang, Jun, Allan J. Barnes, Megan Griffiths, et al.. (2023). Abstract 13857: Slit2/ROBO4 Ligand-Receptor Pair as Novel Biomarkers for Survival in Pulmonary Arterial Hypertension. Circulation. 148(Suppl_1). 1 indexed citations

Berardi, Cecilia, David A. Bluemke, Brian A. Houston, et al.. (2022). Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. The Journal of Heart and Lung Transplantation. 41(5). 619–625. 4 indexed citations

10.

Houston, Brian A., David A. Bluemke, Steven M. Kawut, et al.. (2021). Associations of Angiopoietins With Heart Failure Incidence and Severity. Journal of Cardiac Failure. 27(7). 786–795. 19 indexed citations

11.

Kolb, Todd M., et al.. (2021). How We Would Treat Our Own Pulmonary Hypertension if We Needed to Undergo Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia. 36(6). 1540–1548. 4 indexed citations

12.

Moldobaeva, Aigul, Lan Wang, Laura Johnston, et al.. (2020). Functional Impact of Human Genetic Variants of COL18A1 /Endostatin on Pulmonary Endothelium. American Journal of Respiratory Cell and Molecular Biology. 62(4). 524–534. 22 indexed citations

13.

Crnković, Slaven, Bakytbek Egemnazarov, Rachel L. Damico, et al.. (2018). Disconnect between Fibrotic Response and Right Ventricular Dysfunction. American Journal of Respiratory and Critical Care Medicine. 199(12). 1550–1560. 31 indexed citations

14.

Lahm, Tim, Ivor S. Douglas, Stephen L. Archer, et al.. (2018). Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 198(4). e15–e43. 212 indexed citations

15.

Kelemen, Benjamin W., Stephen C. Mathai, Rachel L. Damico, et al.. (2017). Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction. Pulmonary Circulation. 7(2). 409–420. 35 indexed citations

16.

Leary, Peter J., Todd M. Kolb, Bradley A. Maron, et al.. (2017). What’s in a side effect? The association between pulmonary vasodilator adverse drug events and clinical outcomes in patients with pulmonary arterial hypertension. International Journal of Cardiology. 240. 386–391. 6 indexed citations

17.

Fallica, Jonathan, Laura Johnston, Bo Kim, et al.. (2015). Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1–p38–Xanthine Oxidoreductase–Dependent Cigarette Smoke–Induced Apoptosis. American Journal of Respiratory Cell and Molecular Biology. 54(4). 504–514. 14 indexed citations

18.

Tedford, Ryan J., Benjamin W. Kelemen, Stephen C. Mathai, et al.. (2014). Abstract 11450: Comparison of Simplified (Single-beat) Estimates to Measured Right Ventricular End-Systolic Elastance and RV-Pulmonary Vascular Coupling in Patients With Pulmonary Hypertension. Circulation. 1 indexed citations

19.

Fallica, Jonathan, Laurent Boyer, Bo Kim, et al.. (2014). Macrophage Migration Inhibitory Factor Is a Novel Determinant of Cigarette Smoke–Induced Lung Damage. American Journal of Respiratory Cell and Molecular Biology. 51(1). 94–103. 24 indexed citations

20.

Tedford, Ryan J., Claude A. Beaty, Stephen C. Mathai, et al.. (2013). Abstract 15865: Diastolic Pulmonary Artery Pressure to Pulmonary Capillary Wedge Pressure Gradient (DPG) in Over 5700 Patients With an Elevated Transpulmonary Gradient Does Not Predict Survival After Cardiac Transplantation. Circulation. 128. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact